6533b7dafe1ef96bd126ed79

RESEARCH PRODUCT

Molecular endoscopic imaging: the future is bright

H NeumannShakil AhmedPeter R. Galle

subject

medicine.medical_specialtyex vivo studyReviewAntibody labeling03 medical and health sciencesEndoscopic imagingconfocal endomicroscopy0302 clinical medicinemedicinelcsh:RC799-869Stage (cooking)endoscopySurvival rateIdeal (set theory)medicine.diagnostic_testbusiness.industryGastroenterologymolecular imagingEndoscopy030220 oncology & carcinogenesislcsh:Diseases of the digestive system. Gastroenterology030211 gastroenterology & hepatologyRadiologyMolecular imagingin vivo imagingbusinessPreclinical imagingantibody labeling

description

The prediction and final survival rate of gastrointestinal cancers are dependent on the stage of disease. The ideal would be to detect those gastrointestinal lesions at early stage or even premalignant forms which are difficult to detect by conventional endoscopy with white light optical imaging as they show minimum or no changes in morphological characteristics and are thus left untreated. The introduction of molecular imaging has greatly changed the pattern for detecting gastrointestinal lesions from purely macroscopic structural imaging to the molecular level. It allows microscopic examination of the gastrointestinal mucosa with endoscopy after the topical or systemic application of molecular probes. In recent years, major advancements in endoscopic instruments and specific molecular probes have been achieved. This review focuses on the current status of endoscopic imaging and highlights the application of molecular imaging in gastrointestinal and hepatic disease in the context of diagnosis and therapy based on recently published literature in this field. We also discuss the challenges of molecular endoscopic imaging, its future directions and potential that could have a tremendous impact on endoscopic research and clinical practice in future.

10.1177/2631774519867175http://europepmc.org/articles/PMC6724493